Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China

BACKGROUND: Hepatitis B vaccine (HepB) has been routinely recommended as part of the immunization program in China and has had a satisfactory safety and effectiveness profile in protecting infants from hepatitis B virus infection. We evaluated the surveillance sensitivity and changes over time of AE...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao, Huang, Ninghua, Lu, Qing-Bin, Black, Steven, Liang, Xiaofeng, Cui, Fuqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561938/
https://www.ncbi.nlm.nih.gov/pubmed/36248783
http://dx.doi.org/10.3389/fimmu.2022.956473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561938/
https://www.ncbi.nlm.nih.gov/pubmed/36248783
http://dx.doi.org/10.3389/fimmu.2022.956473

Ejemplares similares